Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Lipids: Dietary Sources and Requirements

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Search research articles

Home
Research Domains
Engineering
Environmental Engineering
Air Pollution Modelling And Control
Reducing Pm2.5 Exposure Lowers Dyslipidemia Risk: A Longitudinal Quasi-experimental Study.

Home
Research Domains
Engineering
Environmental Engineering
Air Pollution Modelling And Control
Reducing Pm2.5 Exposure Lowers Dyslipidemia Risk: A Longitudinal Quasi-experimental Study.

Related Experiment Video

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Reducing PM2.5 exposure lowers dyslipidemia risk: a longitudinal quasi-experimental study.

Dezhong Chen¹, Yiyue Yin¹, Dongmei Yu^2,3

¹Department of Biomedical Sciences, College of Biomedicine, City University of Hong Kong, Hong Kong SAR, China.

American Journal of Epidemiology

|August 29, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Reducing fine particulate matter (PM2.5) exposure significantly lowers the risk of dyslipidemia and improves lipid profiles. This study provides evidence for the health benefits of cleaner air on cardiovascular health.

Keywords:

PM2.5 cardiovascular disease dyslipidemia quasi-experimental study

More Related Videos

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Published on: December 10, 2021

Shotgun Lipidomics of Rodent Tissues

Shotgun Lipidomics of Rodent Tissues

Published on: November 18, 2022

Related Experiment Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Published on: December 10, 2021

Shotgun Lipidomics of Rodent Tissues

Shotgun Lipidomics of Rodent Tissues

Published on: November 18, 2022

Area of Science:

Environmental Health
Cardiovascular Health
Epidemiology

Background:

Limited evidence exists on the impact of improved air quality on lipid health.
Dyslipidemia is a significant risk factor for cardiovascular diseases.
Particulate matter (PM2.5) is a major air pollutant with known adverse health effects.

Purpose of the Study:

To investigate the association between reduced PM2.5 exposure and the risk of dyslipidemia.
To examine the effects of PM2.5 reduction on specific lipid abnormalities.
To provide evidence for the health benefits of air quality improvement.

Main Methods:

Longitudinal quasi-experimental study using Taiwan and Hong Kong MJ cohorts (2000-2018).
Propensity score matching to compare adults with consistently high PM2.5 exposure versus those with reduced exposure.

Cox regression models with time-dependent covariates to analyze PM2.5 reduction and dyslipidemia risk.

Main Results:

Reduced PM2.5 exposure was associated with a significantly lower risk of dyslipidemia (HR = 0.75).
Observed non-linear concentration-response relationships between PM2.5 reduction and lipid health.
Significant improvements in lipid profiles, including reduced total cholesterol, LDL-C, and increased HDL-C.

Conclusions:

Reducing PM2.5 exposure significantly decreases the risk of dyslipidemia.
Air quality improvement leads to better lipid profiles, indicating cardiovascular benefits.
This study offers direct evidence supporting public health initiatives for cleaner air.